<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-04-25T14:50:59Z</responseDate>
  <request identifier="oai:pub.unibl.org:40752" metadataPrefix="oai_dcterms" verb="GetRecord">https://www.pub.unibl.org/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pub.unibl.org:40752</identifier>
        <datestamp>2025-12-10T04:43:24Z</datestamp>
      </header>
      <metadata>
        <oai_dcterms:dcterms xmlns:oai_dcterms="http://www.openarchives.org/OAI/2.0/oai_dcterms/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dcterms/ http://www.openarchives.org/OAI/2.0/oai_dcterms.xsd">
          <dcterms:title>Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort</dcterms:title>
          <dcterms:creator xsi:type="dcterms:URI" title="Graham R. Foster">/unibl/author/Graham R. Foster</dcterms:creator>
          <dcterms:creator xsi:type="dcterms:URI" title="Carmine Coppola">/unibl/author/Carmine Coppola</dcterms:creator>
          <dcterms:creator xsi:type="dcterms:URI" title="Moutaz Derbala Derbala">/unibl/author/Moutaz Derbala Derbala</dcterms:creator>
          <dcterms:creator xsi:type="dcterms:URI" title="peter Ferenci">/unibl/author/peter Ferenci</dcterms:creator>
          <dcterms:creator xsi:type="dcterms:URI" title="Антонија Верхаз">https://www.unibl.org/sr-lat/fis/zaposlen/3299-antonija-verhaz</dcterms:creator>
          <dcterms:date>2016-04</dcterms:date>
          <dcterms:type>Academic Article</dcterms:type>
          <dcterms:type>text</dcterms:type>
          <dcterms:format>20</dcterms:format>
          <dcterms:format>1</dcterms:format>
          <dcterms:identifier>/unibl/sci/idNaucniRad:17049</dcterms:identifier>
          <dcterms:relation xsi:type="dcterms:URI" title="Медицински факултет">https://med.unibl.org</dcterms:relation>
          <dcterms:relation>PLOS ONE</dcterms:relation>
          <dcterms:relation>1932-6203</dcterms:relation>
          <dcterms:isPartOf>PLOS ONE</dcterms:isPartOf>
          <dcterms:isPartOf>1932-6203</dcterms:isPartOf>
          <dcterms:references xsi:type="dcterms:URI">10.1371/journal.pone.0151703</dcterms:references>
          <dcterms:bibliographicCitation>G. Foster, C. Coppola, M. Derbala, P. Ferenci, A. Verhaz, Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort, PLOS ONE, Vol. 11, No. 3, pp. 1 - 20, Apr, 2016</dcterms:bibliographicCitation>
          <dcterms:identifier xsi:type="dcterms:URI">https://www.pub.unibl.org/s/cir/item/40752</dcterms:identifier>
        </oai_dcterms:dcterms>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>